Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case–control study,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case–control study
European Journal of Neurology ( IF 4.5 ) Pub Date : 2020-12-04 , DOI: 10.1111/ene.14663
Zihan Chang ₁ , Haiqiang Zou ₂ , Zhenchao Xie ₁ , Bin Deng ₁ , Rongfang Que ₁ , Zifeng Huang ₁ , Guomei Weng ₃ , Zhihuan Wu ₃ , Ying Pan ₄ , Yanping Wang ₄ , Mengyan Li ₅ , Huifang Xie ₁ , Shuzhen Zhu ₁ , Li Xiong ₆ , Vincent Ct Mok ₆ , Kunlin Jin ₇ , Midori A Yenari ₈ , Xiaobo Wei ₁ , Qing Wang ₁

Affiliation

The aim of this study was to explore whether cystatin C (CysC) could be used as a potential predictor of clinical outcomes in acute ischemic stroke (AIS) patients treated with intravenous tissue plasminogen activator (IV‐tPA).

中文翻译：